We observed that somatic mutations in TP53 were significantly correlated with the CMP-pattern phenotype, whereas mutations in RUNX1, DNMT3A, BCOR and STAG2 were enriched in patients with GMP-pattern MDS (Fig. 1f). Here, TP53 is linked to myelodysplastic syndrome.